Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

These 5 Stocks Dominate Farallon Capital’s Portfolio

Page 1 of 2

Farallon Capital, led by Thomas Steyer, recently filed its latest 13F with the Securities and Exchange Commission, revealing an equity portfolio worth $7.6 billion at the end of the third quarter. According to the filing, Farallon Capital acquired stakes in over 20 companies, while reducing its holdings in ten stocks. Furthermore, the investor unloaded its entire stake in more than 35 companies, including Hospira Inc. (NYSE:HSP), during the difficult quarter for investors. Founded by Thomas Steyer in 1986, Farallon Capital is one of over 700 hedge funds tracked by Insider Monkey. The fund makes investments in economies around the world, including both developed and emerging markets, and public and private debt. Mr. Steyer uses a variety of strategies, include credit investments, value investments, event-driven investments, merger arbitrage, real estate investments, and direct investments, employing them on an opportunistic basis. In this article, we will be taking a closer look at Farallon Capital’s top stocks for the third quarter, starting with search engine giant Google’s parent company.


Most investors don’t understand hedge funds and indicators that are based on hedge funds’ activities. They ignore hedge funds because of their recent poor performance in the bull market. Our research indicates that hedge funds underperformed because they aren’t 100% long. Hedge fund fees are also very large compared to the returns generated and they reduce the net returns experienced by investors. We uncovered that hedge funds’ long positions actually outperformed the market. For instance the 15 most popular small-cap stocks among funds beat the S&P 500 Index by more than 53 percentage points since the end of August 2012. These stocks returned a cumulative of 102% vs. a 48.7% gain for the S&P 500 Index (see more details here). That’s why we believe investors should pay attention to what hedge funds are buying (rather than what their net returns are).

Thomas Steyer
Thomas Steyer
Farallon Capital

#5 Alphabet Inc (NASDAQ:GOOG)

– Shares held (as of September 30): 386,000

– Total Value (as of September 30): $234.85 million

Farallon Capital increased its position in Alphabet Inc (NASDAQ:GOOG) by 116% during the quarter, which shows its confidence in the stock, which has increased by 27.17% since September 30, and 43.73% year-to-date. Alphabet Inc (NASDAQ:GOOG) is making a bigger move into cloud-computing, as the company recently hired Diane Greene, former boss and co-founder of VMware, Inc. (NYSE:VMW), to lead its cloud-computing business. This indicates that the company is getting serious about cloud-computing, where it will face tough competition from big players, Inc. (NASDAQ:AMZN) and Microsoft Corporation (NASDAQ:MSFT). Google CEO Sundar Pichai said in a blog post that “this is an important and fast-growing area for Google and we’re investing for the future.” Another investor betting big on Alphabet Inc (NASDAQ:GOOG) is Andreas Halvorsen’s Viking Global, which held 2.53 million shares as of the end of the third quarter.

Follow Google Inc. (NASDAQ:GOOG)
Trade (NASDAQ:GOOG) Now!

#4 Allergan PLC (NYSE:AGN)

– Shares held (as of September 30): 894,411

– Total Value (as of September 30): $243.11 million

Farallon Capital cut its stake in Allergan PLC (NYSE:AGN) by 24,873 shares during the quarter. Shares of Allergan’s stock surged by 3.68% on Friday on rumors that Allergan and Pfizer Inc. (NYSE:PFE) are going to enter into a merger agreement on Monday. Some unnamed people told Bloomberg that Pfizer can make a bid of $370-to-$380 for each share of Allergan in a deal valued at around $150 billion. The merger will allow New York-based Pfizer to move its headquarters to Ireland, where Allergan is registered. This move would allow Pfizer to save billions of dollars in taxes. Year-to-date Allergan PLC (NYSE:AGN)’s shares have increased by 21.53%. Billionaire activist investor Dan Loeb of Third Point was holding 3.67 million shares of Allergan as of the end of the third quarter.

Follow Allergan Plc (NYSE:AGN)
Trade (NYSE:AGN) Now!

We will be analyzing Farallon Capital’s top three stocks on the next page.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!